BAJAJ FINSERV HEALTHCARE FUND - REGULAR - GROWTH
NAV as on 2026-07-17 · Equity · Sectoral/Thematic
AUM
₹354 Cr
1Y Return
+10.9%
3Y CAGR
-
5Y CAGR
-
Expense
2.09%
Risk
Very High
1Y Return
+10.9%
3Y CAGR
-
5Y CAGR
-
Since Inception
+6.2%
AI Fund Analysis
Get AI-powered verdict, strengths, risks, and SIP recommendations for this fund.
NAV History
Drag or scroll the chart to pan through history
52-Week NAV Range
95% from 52W low
Fund Information
Fund House
Bajaj Finserv Mutual Fund
Category
Equity - Sectoral/Thematic
Min SIP
₹500
Min Lumpsum
₹5,000
Portfolio Composition
Asset Allocation
Market Cap Split
Top Holdings
Divi's Laboratories Ltd
Healthcare
Apollo Hospitals Enterprise Ltd
Healthcare
Aurobindo Pharma Ltd
Healthcare
Sun Pharmaceuticals Industries Ltd
Healthcare
Piramal Pharma Ltd
Healthcare
Rubicon Research Ltd
Healthcare
Torrent Pharmaceuticals Ltd
Healthcare
Neuland Laboratories Ltd
Healthcare
Emcure Pharmaceuticals Ltd
Healthcare
Max Healthcare Institute Ltd Ordinary Shares
Healthcare
Sector Allocation
Fundamentals
P/E Ratio
46.88
Cat avg: 42.12
P/B Ratio
6.28
Cat avg: 6.03
Dividend Yield
0.39%
Cat avg: 0.61%
Price/Sale
5.69
Price/Cash Flow
30.56
Peer Comparison
| Fund | AUM (Cr) | Exp % | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Bajaj Healthcare Reg Gr | 354 | 2.09 | +10.9% | - | - |
| Nippon India Pharma Gr | 9,044 | 1.52 | +6.6% | +19.8% | +12.3% |
| ICICI Pru Pharma Healthcare Diag Gr | 6,625 | 1.55 | +6.4% | +24.5% | +15.5% |
| SBI Healthcare Opportunities Reg Gr | 4,998 | 1.88 | +13.6% | +23.4% | +16.2% |
| DSP Healthcare Fund Reg Gr | 3,514 | 1.66 | +8.7% | +21.4% | +14.5% |
| Mirae Asset Healthcare Reg Gr | 3,253 | 1.66 | +11.7% | +22.8% | +13.8% |
| HDFC Pharma and Healthcare Reg Gr | 2,611 | 2.16 | +17.9% | - | - |
| Tata India Pharma & Healthcare Reg Gr | 1,455 | 1.84 | +6.7% | +20.7% | +13.1% |
| UTI Healthcare Reg Gr | 1,308 | 2.26 | +11.6% | +25.2% | +14.2% |
| Aditya BSL Pharma & Hlthcare Reg Gr | 1,011 | 1.92 | +13.3% | +22.0% | +13.0% |
What If I Had Invested?
NAV history not available for this range
Key Metrics
Risk-o-Meter
Low
Moderate
High
Very High
Rated as Very High risk
Disclaimer: Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. NAV data sourced from AMFI. This is not SEBI-registered investment advice.